Literature DB >> 476923

Metabolic balance of aluminum studied in six men.

J E Gorsky, A A Dietz, H Spencer, D Osis.   

Abstract

The metabolism of aluminum was followed in patients who were receiving strictly controlled diets, either unaltered or supplemented with aluminum-containing antacids. Aluminum was determined by atomic absorption spectrophotometry with a graphite furnace. All food, water, and medications were analyzed, as were aliquots of urine and stool collected throughout six-day periods. Patients were usually studied for five consecutive six-day periods on the same diet and aluminum intake. This study included six patients who were studied for seven to 21 such six-day periods. During control periods, when the patients were receiving less than 5 mg of aluminum per day, the balance was usually slightly negative, but when the diet was supplemented with antacids to contain 1--3 g of aluminum per day, an average positive balance of 23 to 313 mg of aluminum per day was observed for the total time on the same intake. Consecutive six-day periods while a subject was receiving antacids might show either positive or negative balances, but the average retention for 18--84 days on antacids was always positive. Thus the potential effects of the storage of aluminum in the tissues must be considered in the chronic administration of antacids.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476923

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Review of epidemiologic studies of aluminium and neurological disorders.

Authors:  G F Craun
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

3.  Serum aluminium levels of intensive care patients treated with two different antacids for prevention of stress ulceration.

Authors:  H Rauch; F Fleischer; H Böhrer; G Jürs; M Wilhelm; C Krier
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 4.  Assessing the safety of drugs for the long-term treatment of peptic ulcers.

Authors:  K G Wormsley
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

5.  Determination by flameless atomic absorption of aluminium in serum and hair for toxicological monitoring of patients on chronic intermittent haemodialysis.

Authors:  H J De Groot; E J De Haas; P D'Haese; A Heyndrickx; F A De Wolff
Journal:  Pharm Weekbl Sci       Date:  1984-02-24

Review 6.  Aluminum toxicity.

Authors:  A C Alfrey
Journal:  Bull N Y Acad Med       Date:  1984-03

Review 7.  [Aluminum toxicity].

Authors:  H V Henning
Journal:  Klin Wochenschr       Date:  1989-12-15

8.  Aluminum accumulation in serum, liver and spleen of Fe-depleted and Fe-adequate rats.

Authors:  T S Brown; R Schwartz
Journal:  Biol Trace Elem Res       Date:  1992-07       Impact factor: 3.738

9.  Radiographic manifestations of experimental aluminum toxicity in growing bone.

Authors:  R J Hernandez; A B Sedman; D M Smid; W G Goodman
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

10.  A method of studying the intestinal absorption of aluminium in the rat.

Authors:  G B van der Voet; F A de Wolff
Journal:  Arch Toxicol       Date:  1984-09       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.